Ultrasound-guided high-intensity focused ultrasound combined with pd-1 blockade in patients with liver metastases from lung cancer: protocol for a single-arm phase 2 trial

HIGHLIGHTS

• What: The aim is to determine the overall response rate based on immune-related response criteria. This study seeks to improve treatment outcomes for lung cancer patients with liver metastases by combining HIFU and PD-1 inhibition. The study also aims to identify potential biomarkers through exploratory research that can aid in selecting patients for optimized outcomes in the future. The authors propose that localized therapies targeting hepatic metastases, such as RT, may enhance the efficacy of ICB in patients with liver metastases.
• Who: Unknown from the Respiratory Department, Central Hospital, China State Key Laboratory . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.